Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Outcome in 217 patients.

作者: Namio Kodama , Tatsuya Sasaki , Masahisa Kawakami , Masahiro Sato , Jun Asari

DOI: 10.1016/S0090-3019(99)00183-4

关键词:

摘要: Abstract BACKGROUND Cisternal irrigation therapy with urokinase and ascorbic acid was introduced to prevent symptomatic vasospasm after aneurysmal subarachnoid hemorrhage (SAH). To dissolve wash out the clot, cisternal is used. Ascorbic added degenerate oxy-hemoglobin, one of strongest spasmogenic substances, into verdohemelike products, which are nonspasmogenic. The efficacy safety this were evaluated. METHODS This performed consecutively in 217 patients. degree SAH patients classified as Fisher CT Group 3, highest number (Hounsfield number) exceeded 60 SAH, suggested a significant risk for vasospasm. All underwent surgery within 72 hours from onset SAH. After clipping aneurysm, tubes placed Sylvian fissure (inlet) unilaterally or bilaterally prepontine chiasmal cistern (outlet). Lactated Ringer’s solution (120 IU/mL) (4 mg/mL) infused at rate 30 mL/hour/side approximately 10 days. RESULTS Of studied, observed 6 cases (2.8%), two these six (0.9%) demonstrated sequelae. average total blood volume calculated drainage fluid 114 mL. Analysis absorption spectrum revealed disappearance oxy-hemoglobin-specific 576-nm peak. Complications occurred eight during therapy; experienced seizures, developed meningitis, four had an intracranial hemorrhage. However, all recovered without neurological deficits. CONCLUSIONS These results suggest that effective preventing

参考文章(25)
N.W.C. Dorsch, A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage Journal of Clinical Neuroscience. ,vol. 1, pp. 151- 160 ,(1994) , 10.1016/0967-5868(94)90021-3
Tatsuya Sasaki, Masato Matsumoto, Kyouichi Suzuki, Yutaka Konno, Jun Sakuma, Namio Kodama, Prevention of vasospasm—cisternal irrigation therapy with urokinase and ascorbic acid International Congress Series. ,vol. 1247, pp. 611- 622 ,(2002) , 10.1016/S0531-5131(02)01105-6
Joseph M Zabramski, Robert F Spetzler, K Stuart Lee, Stephen M Papadopoulos, Edwin Bovill, Richard S Zimmerman, Joshua B Bederson, None, Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery. ,vol. 75, pp. 189- 196 ,(1991) , 10.3171/JNS.1991.75.2.0189
Kazuo Mizoi, Takashi Yoshimoto, Akira Takahashi, Satoru Fujiwara, Keiji Koshu, Takayuki Sugawara, Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator. Journal of Neurosurgery. ,vol. 78, pp. 430- 437 ,(1993) , 10.3171/JNS.1993.78.3.0430
Kunihiko Osaka, Prolonged vasospasm produced by the breakdown products of erythrocytes Journal of Neurosurgery. ,vol. 47, pp. 403- 411 ,(1977) , 10.3171/JNS.1977.47.3.0403
Gary K. Steinberg, Marc A. Vanefsky, Michael P. Marks, John R. Adler, George H. Koenig, Failure of intracisternal tissue plasminogen activator to prevent vasospasm in certain patients with aneurysmal subarachnoid hemorrhage. Neurosurgery. ,vol. 34, pp. 809- 814 ,(1994) , 10.1227/00006123-199405000-00004
J. Max Findlay, Bryce K. A. Weir, Neal F. Kassell, Lew B. Disney, Michael G. A. Grace, Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage Journal of Neurosurgery. ,vol. 75, pp. 181- 188 ,(1991) , 10.3171/JNS.1991.75.2.0181
David J. Boullin, Lennart Brandt, Bengt Ljunggren, Philip Tagari, Vasoconstrictor activity in cerebrospinal fluid from patients subjected to early surgery for ruptured intracranial aneurysms Journal of Neurosurgery. ,vol. 55, pp. 237- 245 ,(1981) , 10.3171/JNS.1981.55.2.0237
K Mizoi, T Yoshimoto, S Fujiwara, T Sugawara, A Takahashi, K Koshu, Prevention of vasospasm by clot removal and intrathecal bolus injection of tissue-type plasminogen activator: preliminary report. Neurosurgery. ,vol. 28, pp. 807- 813 ,(1991) , 10.1097/00006123-199106000-00004